Thermo Fisher Scientific Currently Up Six Consecutive Days, on Track for Longest Winning Streak Since March 2022 — Data Talk
Thermo Fisher Scientific Inc. (TMO) is currently at $584.75, up $4.91 or 0.85%
--Would be highest close since May 23, 2024, when it closed at $585.03
--Currently up six consecutive days; up 3.91% over this period
--Longest winning streak since March 21, 2022, when it rose for six straight trading days
--Best six day stretch since the six days ending May 16, 2024, when it rose 4.1%
--Up 2.95% month-to-date
--Up 10.17% year-to-date
--Down 12.36% from its all-time closing high of $667.24 on Dec. 31, 2021
--Up 12.85% from 52 weeks ago (June 9, 2023), when it closed at $518.18
--Down 2.45% from its 52-week closing high of $599.43 on March 11, 2024
--Up 35.54% from its 52-week closing low of $431.41 on Oct. 27, 2023
--Traded as high as $585.95; highest intraday level since May 24, 2024, when it hit $587.96
--Up 1.05% at today's intraday high
All data as of 12:13:39 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
June 07, 2024 12:32 ET (16:32 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Six Sports Betting and iGaming Stocks Trading at a Discount
-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations